Large drugmakers with the fastest earnings growth

Ranked

25

of 412 large drugmakers we cover

Median

−0.3%

Highest

+227.1%

INDV

Range

−89.0% to +227.1%

#	Company	EPS growth	PE	Revenue growth (TTM)	Market cap
1	INDVIndivior Pharmaceuticals	+227.1%	12.4×	+13.5%	$4.1B
2	RIGLRigel Pharmaceuticals	+196.7%	n/m	+3.3%	$899.1M
3	CRMDCorMedix	+184.0%	3.7×	+280.5%	$611.9M
4	PAHCPhibro Animal Health	+106.8%	15.9×	+17.1%	$1.6B
5	LLYEli Lilly and	+94.8%	42.7×	+49.6%	$1.2T
6	BMYBristol-Myers Squibb	+83.1%	13.5×	+3.1%	$125.6B
7	ABBVAbbVie	+68.6%	80.7×	+10.4%	$504.8B
8	ACADAcadia Pharmaceuticals	+66.2%	n/m	+11.8%	$3.4B
9	PTGXProtagonist Therapeutics	+47.1%	134×	+34.8%	$9B
10	NATRNatures Sunshine Products	+36.5%	12.0×	+6.8%	$213.8M
11	AMGNAmgen	+31.6%	27.3×	+9.1%	$237.5B
12	COLLCollegium Pharmaceutical	+19.2%	18.5×	+14.3%	$747.5M
13	HRMYHarmony Biosciences	−0.3%	11.7×	+24.3%	$2.1B
14	PBHPrestige Consumer Healthcare	−16.2%	13.4×	−1.4%	$2.3B
15	JNJJohnson & Johnson	−36.3%	40.0×	+7.8%	$635.8B
16	AMPHAmphastar Pharmaceuticals	−36.3%	14.8×	+1.0%	$1.1B
17	LFVNLifevantage	−45.9%	14.7×	−20.1%	$73.4M
18	BIIBBiogen	−46.0%	44.4×	+0.3%	$37B
19	PBYIPuma Biotechnology	−46.9%	21.2×	−2.9%	$568.9M
20	PFEPfizer	−59.6%	39.5×	−0.2%	$171.2B
21	CORTCorcept Therapeutics	−62.8%	204×	+16.0%	$9.3B
22	OGNOrganon	−71.4%	17.9×	−2.5%	$3.6B
23	MRKMerck	−80.7%	116×	+4.6%	$358.4B
24	ALKSAlkermes plc.	−81.7%	115×	+10.8%	$7.3B
25	BMRNBiomarin Pharmaceutical	−89.0%	151×	+11.2%	$10.8B

Not ranked: 293 with not a meaningful number, 19 with a quarter missing, 16 with no profit to compare, 5 with growth above 300% (a base too small to compare). 54 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.